Factor 8 Ehl denied for missing prior authorization by Humana?

Humana's specific coverage criteria for factor 8 ehl are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Requires Prior Authorization for Extended Half-Life Factor VIII

Extended half-life (EHL) Factor VIII products are specialty biologics with significant per-unit costs. Humana, like most major insurers, requires prior authorization (PA) before dispensing these products to confirm medical necessity, appropriate diagnosis, and prescriber qualifications. A prior-auth-required denial means the claim was submitted without an approved PA on file — either because the PA was never requested, was requested but denied, or expired before the prescription was filled.

## Why This Denial Is Appealable

A PA denial is a coverage determination, not just an administrative hurdle. If the underlying clinical need is well-documented and meets Humana's published criteria, the denial is appealable. Patients have strong protections under federal law to contest PA decisions, particularly for treatments managing serious chronic conditions like Hemophilia A.

## Federal Appeal Rights

• ERISA §503 (employer-sponsored plans): Right to a full-and-fair internal review, followed by external review.
• ACA §2719 (non-grandfathered plans): External review by an Independent Review Organization (IRO). Request the external review no later than approximately four months after the final internal denial — confirm the exact deadline on your denial notice.
• Expedited PA/appeal: If your condition requires urgent treatment, request expedited review; a decision is typically required within 72 hours of the request.

## Appeal Process and Timeline

1. If the original PA was never filed, submit it immediately — include all clinical documentation from the outset. 2. If the PA was denied, request the specific criteria applied and the clinical reason for denial. 3. File a Level 1 internal appeal within the timeframe specified on the denial letter. 4. If upheld, escalate to Level 2 internal appeal or external IRO review. 5. For urgent situations, request expedited review at any stage.

## Documentation to Gather

• Diagnosis documentation: Lab-confirmed Hemophilia A with Factor VIII activity level.
• Treatment history: Complete history of all prior Factor VIII products used — names, durations, outcomes, and documented reasons for any changes.
• Prescriber credentials: Confirmation that the ordering provider is a hematologist or a specialist with documented hemophilia treatment experience.
• Medical-necessity letter: A detailed letter from the hematologist explaining why EHL Factor VIII is required, referencing the patient's bleeding phenotype, venous access status, adherence history, and relevant WFH/MASAC guidance.
• Humana's published PA criteria: Download the current medical policy and use it as a checklist — the appeal must directly address each listed criterion.

## Criteria-Mapping Structure

Obtain the PA criteria from Humana's provider portal and map each requirement explicitly:

| PA Criterion | Patient-Specific Evidence | |---|---| | Confirmed Hemophilia A diagnosis | Genetic/lab documentation | | Specialty prescriber | Hematologist credentials | | Prior standard Factor VIII use (if required) | Pharmacy and infusion center records | | Clinical rationale for EHL formulation | Prescriber letter | | Requested product is FDA-approved for this indication | Prescribing label |

A PA appeal with every criterion explicitly answered rarely requires escalation to external review.